Nuñez receives Vallee Scholar Award
James Nuñez, assistant professor of molecular and cell biology at the University of California, Berkeley, has been named a 2025 Vallee Scholar by the Vallee Foundation. Established in 2013, the Vallee Scholar Awards program provides flexible, unrestricted funding to outstanding early-career investigators conducting basic biomedical research. According to the Vallee Foundation, Nuñez’s work on CRISPR-based genome and epigenome editing, “exemplifies the program’s mission to support bold, curiosity-driven science that pushes the boundaries of our understanding of human biology.” He will receive $400,000 to support his research.
Nuñez’s research focuses on understanding DNA methylation — the most abundant epigenetic modification in humans — and its roles in health, disease and aging. His team uses advanced CRISPR technologies and stem cell models of neuronal differentiation. They aim to uncover how unique DNA methylation patterns are established in neurons and how their misregulation contributes to human disease.
Nuñez has received many awards, including a Hanna Gray Fellowship from the Howard Hughes Medical Institute, the Pew Biomedical Scholars Award and the Alfred P. Sloan Research Fellowship.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles
Mydy named Purdue assistant professor
Her lab will focus on protein structure and function, enzyme mechanisms and plant natural product biosynthesis, working to characterize and engineer plant natural products for therapeutic and agricultural applications.
In memoriam: Michael J. Chamberlin
He discovered RNA polymerase and was an ASBMB member for nearly 60 years.
Building the blueprint to block HIV
Wesley Sundquist will present his work on the HIV capsid and revolutionary drug, Lenacapavir, at the ASBMB Annual Meeting, March 7–10, in Maryland.
In memoriam: Alan G. Goodridge
He made pioneering discoveries on lipid metabolism and was an ASBMB member since 1971.
Alrubaye wins research and teaching awards
He was honored at the NACTA 2025 conference for the Educator Award and at the U of A State and National Awards reception for the Faculty Gold Medal.
Designing life’s building blocks with AI
Tanja Kortemme, a professor at the University of California, San Francisco, will discuss her research using computational biology to engineer proteins at the 2026 ASBMB Annual Meeting.